Lv42
620 积分 2025-10-22 加入
Strengthening muscle for healthy ageing: innovative treatments for sarcopenia
8天前
已完结
Unravelling the GIPR agonist versus antagonist paradox
10天前
已完结
A Phase 1, Randomised, Double‐Blind, Placebo‐Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP ‐ 1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity
13天前
已完结
Safety and efficacy of subcutaneous injection with HMI-115 versus placebo in endometriosis-associated pain in premenopausal women: a multicentre, double-blind, randomised, proof-of-concept phase 2 trial
23天前
已完结
The complex patent situation regarding antibody Fc engineering
1个月前
已完结
The past, present and future of de novo protein design
4个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
5个月前
已完结
AI-driven protein design
9个月前
已完结
皖公网安备34019202002308
